Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.31 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20175197 | 0.90 | PDK2 (0.37) | PDK2 | |
| SCHEMBL20174745 | 0.86 | NTRK1 (0.37) | MAOANTRK1PLK3 | |
| SCHEMBL20174690 | 0.82 | PDK2 (0.41) | PDK2MAOAMAOBNTRK1PLK3 | |
| SCHEMBL16491720 | 0.81 | PDK2 (0.40) | PDK2MAOAMAOBNTRK1PLK3 | |
| SCHEMBL20174706 | 0.81 | PDK2 (0.40) | PDK2CA1CA2 | |
| SCHEMBL16491662 | 0.80 | PDK2 (0.40) | PDK2MAOAMAOB | |
| SCHEMBL16855614 | 0.79 | ALOX5 (0.40) | PDK2MAOAMAOB | |
| SCHEMBL17883218 | 0.79 | PDK2 (0.39) | PDK2MAOAMAOB | |
| SCHEMBL16491899 | 0.79 | AHR (0.41) | PDK2MAOAMAOBNTRK1PLK3 | |
| SCHEMBL29603205 | 0.78 | PDK2 (0.58) | PDK2CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180148639-A1 | SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180148639-A1 | SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, NR2E3, ERG | PDK2 651/4885MAOA 3325/4885MAOB 2875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.